-transparent.png){kind=logo}
Tuberculous pleurisy is a good model for resolution of local cellular immunity. It would be expected that tuberculous pleural fluid contains a variety of immunologically important cytokines because of the accumulation of immunocompetent cells in the pleural cavity. We studied interleukin 1 (IL-1), interleukin 2 (IL-2), and interferon gamma (IFN-gamma) levels in pleural fluid of 20 patients with tuberculous pleurisy and compared them with those in pleural fluid of 20 patients with malignant pleurisy. We also evaluated adenosine deaminase (ADA) levels in both effusions. Tuberculous pleural fluid had higher levels of IL-1, IL-2, IFN-gamma, and ADA than malignant pleural fluid. Although the difference of IL-1 level between tuberculous and malignant pleural fluid was modest, that of IL-2, IFN-gamma, and ADA was dominant. These findings suggest that activated T lymphocytes in tuberculous pleural fluid concern the production of lymphokines at the morbid site and they effectively exert local cellular immunity through the action of such lymphokines.
K Shimokata, and
H Saka, and
T Murate, and
Y Hasegawa, and
T Hasegawa
February 1987,
Rinsho byori. The Japanese journal of clinical pathology,
K Shimokata, and
H Saka, and
T Murate, and
Y Hasegawa, and
T Hasegawa
July 1986,
Nihon Kyobu Shikkan Gakkai zasshi,
K Shimokata, and
H Saka, and
T Murate, and
Y Hasegawa, and
T Hasegawa
April 1989,
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
K Shimokata, and
H Saka, and
T Murate, and
Y Hasegawa, and
T Hasegawa
January 1997,
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
K Shimokata, and
H Saka, and
T Murate, and
Y Hasegawa, and
T Hasegawa
December 1996,
Kekkaku : [Tuberculosis],
K Shimokata, and
H Saka, and
T Murate, and
Y Hasegawa, and
T Hasegawa
September 1984,
Tubercle,
K Shimokata, and
H Saka, and
T Murate, and
Y Hasegawa, and
T Hasegawa
January 2024,
Respiratory investigation,
K Shimokata, and
H Saka, and
T Murate, and
Y Hasegawa, and
T Hasegawa
September 1971,
Connecticut medicine,
K Shimokata, and
H Saka, and
T Murate, and
Y Hasegawa, and
T Hasegawa
October 2009,
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia,
K Shimokata, and
H Saka, and
T Murate, and
Y Hasegawa, and
T Hasegawa
January 2016,
Mediators of inflammation,
